Crescita Secures Line of Credit with the Royal Bank of Canada Following Repayment in Full of Knight Therapeutics Loan

Stock Information for Crescita Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Crescita Therapeutics Inc.

Crescita to Receive One-time Cash Payment Following Amendment to Pliaglis® U.S. Licensing Agreement
Crescita Reports First Quarter 2020 Results
Crescita Therapeutics Announces the Results of its Annual General Meeting of Shareholders
Crescita Therapeutics Announces Extension of First Quarter 2020 Filings Due to COVID-19
Crescita Therapeutics Announces Measures in Response to COVID-19 Virus
Crescita Reports Q4 and Fiscal 2019 Results
Pliaglis® finally available in Canada
Crescita Announces Positive Topline Results from Two Pivotal Phase 3 Clinical Studies for its Lead Pipeline Product in Patients with Plaque Psoriasis

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.